Department Of Cardiothoracic Surgery
Investigator
Michael Argenziano, MD, FACS
Email
ma66@cumc.columbia.edu

Michael Argenziano, MD, FACS, is the chief of adult cardiac surgery, director of the Minimally Invasive Cardiac Surgery and Surgical Arrhythmia programs at NewYork-Presbyterian Hospital, professor of surgery at Columbia University Medical Center, director of the Cardiothoracic Surgery Research Laboratory and Clinical Research Program, and program director of the Thoracic Surgery Residency program. Dr. Argenziano received his medical degree from Columbia University College of Physicians and Surgeons, and completed his postgraduate training at Columbia Presbyterian Hospital.

Dr. Argenziano is board certified in Surgery and Thoracic Surgery. He is the immediate past president of the New York Society for Thoracic Surgery. He has authored more than 100 publications, presented at numerous scientific conferences, and received several grants and awards for his research. He has led two national trials of robotic surgery, and his atrial fibrillation research has been supported by the TSFRE's Career Development Award. He currently serves as Columbia's principal investigator in the NIH/NHLBI Network for Cardiothoracic Surgical Investigations.


Clinical Studies Managed By This Investigator:
Condition Study Title
Transplant [ CLOSED ] Study for patients who require surgery using a hemostatic device called PerClot
Heart Disease [ CLOSED ] Study for patients undergoing cardiac surgery using CytoSorb
Surgery [ CLOSED ] A study for patients who have had Cardiac surgery using study drug QPI-1002